You just read:

Eiger Bio Receives Orphan Designation for Lonafarnib, a First In Class, Investigational Treatment for Hepatitis Delta Virus (HDV) Infection

News provided by

Eiger Bio, Inc.

22 Dec, 2014, 13:00 GMT